Genflow Biosciences plc WQ5.F Stock
Genflow Biosciences plc Price Chart
Genflow Biosciences plc WQ5.F Financial and Trading Overview
| Genflow Biosciences plc stock price | 0.02 EUR |
| Previous Close | 0.04 EUR |
| Open | 0.04 EUR |
| Bid | 0.03 EUR x N/A |
| Ask | 0.04 EUR x N/A |
| Day's Range | 0.04 - 0.04 EUR |
| 52 Week Range | 0.02 - 0.06 EUR |
| Volume | 50K EUR |
| Avg. Volume | 892 EUR |
| Market Cap | 12.07M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
WQ5.F Valuation Measures
| Enterprise Value | 7.88M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.375 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.905 |
Trading Information
Genflow Biosciences plc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 35.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.06 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.03 EUR |
| 200-Day Moving Average | 0.03 EUR |
WQ5.F Share Statistics
| Avg. Volume (3 month) | 892 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 292.51M |
| Float | 103.54M |
| Short Ratio | N/A |
| % Held by Insiders | 82.25% |
| % Held by Institutions | 0.85% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -57.65% |
| Return on Equity (ttm) | -110.28% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1334814 EUR |
| Net Income Avi to Common (ttm) | -1335325 EUR |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.36M EUR |
| Total Cash Per Share (mrq) | 0.008 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 10.419 |
| Book Value Per Share (mrq) | 0.008 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1368324 EUR |
| Levered Free Cash Flow (ttm) | -1013706 EUR |
Profile of Genflow Biosciences plc
| Country | Germany |
| State | N/A |
| City | London |
| Address | 6 Heddon Street |
| ZIP | W1B 4BT |
| Phone | N/A |
| Website | https://genflowbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
Q&A For Genflow Biosciences plc Stock
What is a current WQ5.F stock price?
Genflow Biosciences plc WQ5.F stock price today per share is 0.02 EUR.
How to purchase Genflow Biosciences plc stock?
You can buy WQ5.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genflow Biosciences plc?
The stock symbol or ticker of Genflow Biosciences plc is WQ5.F.
Which industry does the Genflow Biosciences plc company belong to?
The Genflow Biosciences plc industry is Biotechnology.
How many shares does Genflow Biosciences plc have in circulation?
The max supply of Genflow Biosciences plc shares is 369.96M.
What is Genflow Biosciences plc Price to Earnings Ratio (PE Ratio)?
Genflow Biosciences plc PE Ratio is now.
What was Genflow Biosciences plc earnings per share over the trailing 12 months (TTM)?
Genflow Biosciences plc EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Genflow Biosciences plc company belong to?
The Genflow Biosciences plc sector is Healthcare.